Zn2+-dependent misfolding of the p53 DNA binding domain

Biochemistry

Volumn 46, Issue 10, 2007, Pages 2630-2639

  Butler, James S ^a,b   Loh, Stewart N ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLOMERATION; MOLECULAR STRUCTURE; PROTEINS; REACTION KINETICS; STOICHIOMETRY; ZINC COMPOUNDS;

DNA BINDING DOMAIN (DBD); KINETIC FOLDING; METAL BINDING;

DNA SEQUENCES;

CHAPERONE; NITRILOTRIACETIC ACID; PROTEIN P53; ZINC ION;

ARTICLE; BIOAVAILABILITY; COMPLEX FORMATION; KINETICS; METAL BINDING; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN MISFOLDING; REACTION ANALYSIS; STOICHIOMETRY;

BIOLOGICAL AVAILABILITY; DNA; DNA-BINDING PROTEINS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; TUMOR SUPPRESSOR PROTEIN P53; ZINC;

EID: 33947241339     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi062106y     Document Type: Article

References (40)

1. Vogelstein, B., Lane, D., and Levine, A. J. (2000) Surfing the p53 network, Nature 408, 307-310.
2. Olivier, M., Eeles, R., Hollstein, M., Khan, M. A., Harris, C. C., and Hainault, P. (2002) The IARC TP53 database: new online mutation analysis and recommendations to users, Hum. Mutat. 19, 607-614.
3. Cho, Y., Gorina, S., Jeffrey, P. D., and Pavletich, N. P. (1994) Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations, Science 265, 346-355.
4. Bullock, A. N., Henckel, J., DeDecker, B. S., Johnson, C. M., Nikolova, P. V., Proctor, M. R., Lane, D. P., and Fersht, A. R. (1997) Thermodynamic stability of wild-type and mutant p53 core domain, Proc. Natl. Acad. Sci. U.S.A. 94, 14338-14342.
5. Bullock, A. N., Henckel, J., and Fersht, A. R. (2000) Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy, Oncogene 19, 1245-1256.
6. Wong, K.-B., DeDecker, B. S., Freund, S. M., Proctor, M. R., Bycroft, M., and Fersht, A. R. (1999) Hot-spot mutants of p53 core domain evince characteristic local structural changes, Proc. Natl. Acad. Sci. U.S.A. 96, 8438-8442.
7. Butler, J. S., and Loh, S. N. (2005) Kinetic partitioning during folding of the p53 DNA binding domain, J. Mol. Biol. 350, 906-918.
8. Borgia, A., Bonivento, D.. Travaglini-Allocatelli, C., Di Matteo, A., and Brunori, M. (2006) Unveiling a hidden folding intermediate in c-type cytochromes by protein engineering, J. Biol. Chem. 281, 9331-9336.
9. Pocanschi, C. L., Apell, H. J., Puntervoll, P., Hogh, B., Jensen, H. B., Welte, W., and Kleinschmidt, J. H. (2006) The major outer membrane protein of Fusobacterium nucleatum (FomA) folds and inserts into lipid bilayers via parallel folding pathways, J. Mol. Biol. 355, 548-561.
10. Wildegger, G., and Kiefhaber, T. (1997) Three-state model for lysozyme folding: triangular folding mechanism with an energetically trapped intermediate, J. Mol. Biol. 270, 294-304.
11. Wright, C. F., Lindorff-Larsen, K., Randles, L. G., and Clarke, J. (2003) Parallel protein-unfolding pathways revealed and mapped, Nat. Struct. Biol. 10, 658-662.
12. Krantz, B., and Sosnick, T. R. (2001) Engineered metal binding sites map the heterogeneous folding landscape of a coiled coil, Nat. Struct. Biol. 8, 1042-1047.
13. Wallace, L. A., and Matthews, C. R. (2002) Sequential vs. parallel protein-folding mechanisms: experimental tests for complex folding reactions, Biophys. Chem. 101-102, 113-131.
14. Brandts, J. F., Halvorson, H. R., and Brennan, M. (1975) Consideration of the possibility that the slow step in protein denaturation reactions is due to cis-trans isomerism of proline residues, Biochemistry 14, 4953-4963.
15. Kiefhaber, T., Grunert, H. P., Hahn, U., and Schmid, F. X. (1990) Replacement of a cis proline simplifies the mechanism of ribonuclease T1 folding, Biochemistry 35, 1548-1559.
16. Schultz, D. A., Schmid, F. X., and Baldwin, R. L. (1992) Cis proline mutants of ribonuclease A. 11. Elimination of the slow-folding forms by mutation, Protein Sci. 1, 917-924.
17. Wedermeyer, W. J., Welker, E., and Scheraga, H. A. (2002) Proline cis-trans isomerization and protein folding, Biochemistry 451, 14637-14644.
18. Maki, K., Ikura, T., Hayano, T., Takaliashi, N., and Kuwajima, K. (1999) Effects of proline mutations on the folding of staphylococcal nuclease, Biochemistry 38, 2213-2223.
19. Wu, Y., and Matthews, C. R. (2003) Proline replacements and the simplification of the complex, parallel channel folding mechanism for the alpha subunit fo Tip synthase, a TIM barrel protein, J. Mol. Biol. 330, 1131-1144.
20. Butler, J. S., and Loh, S. N. (2003) Structure, function, and aggregation of the zinc-free form of the p53 DNA binding domain, Biochemistry 42, 2396-2403.
21. 2+ on DNA recognition and stability of the p53 DNA binding domain, Biochemistry 45, 7483-7492.
22. Colón, W., Wakem, L. P., Sherman, F., and Roder, H. (1997) Identification of the predominant non-native histidine ligand in unfolded cytochrome c, Biochemistry 36, 12535-12541.
23. 2+ binding on the folding kinetics of α-lactalbumin, J. Mol. Biol. 206, 547-561.
24. Bushmarina, N. A., Blanchet, C. E., Vernier, G., and Forge, V. (2006) Cofactor effects on the protein folding reaction: acceleration of α-lactalbumin refolding by metal ions, Protein Sci. 15, 659-671.
25. Apiyo, D., and Wittung-Stafshede, P. (2002) Presence of the cofactor speeds up folding of Desulfovibrio desulfuricans flavodoxin, Protein Sci. 11, 1129-1135.
26. Sugawara, T., Kuwajima, K., and Sugai, S. (1991) Folding of staphylococcal nuclease A studied by equilibrium and kinetic circular dichroism spectra, Biochemistry 30, 2698-2706.
27. Pozdnyakova, I., and Wittung-Stafshede, P. (2001) Copper stabilizes azurin by decreasing the unfolding rate, Arch. Biochem. Biophys. 290, 146-148.
28. Goedken, E. R., Keck, J. L., Berger, J. M., and Marqusee, S. (2000) Divalent metal cofactor binding in the kinetic folding trajectory of Escherichia coli ribonuclease H1, Protein Sci. 9, 1914-1921.
29. Hunt, J. B., Neece, S. H., and Ginsburg, A. (1985) The use of 4-(2-pyridylazo)resorcinol in studies of zinc release from Escherichia coli aspartate transcarbamoylase, Anal. Biochem. 146, 150-157.
30. Nicholls, C. D., McLure, K. G., Shields, M. A., and Lee, P. (2002) Biogenesis of p53 involves cotranslational dimerization of monomers and posttranslational dimerization of dimers. Implications on the dominant negative effect, J. Biol. Chem. 277, 12937-12945.
31. Pace, C. N., and Scholtz, J. M. (1997) Protein Structure: a Pratical Approach (Creighton, T. E., Ed.) pp 299-320, Oxford University Press, New York.
32. Butler, J. S., and Loh, S. N. (2006) Folding and misfolding mechanisms of the p53 DNA binding domain at physiological temperature, Protein Sci. (in press).
33. 2+-protein interactions, Anal. Biochem. 187, 328-336.
34. Martell, A. E., and Smith, R. M. (1974-1989) Critical Stability Constants, Vol. 1-6, Plenum Press, New York.
35. Friedler, A., Veprintsev, D. B., Hansson, L. O., and Fersht, A. R. (2003) Kinetic instability of p53 core domain mutants, J. Biol. Chem. 278, 24108-24112.
36. Meplan, C., Mann, K., and Hainaut, P. (1999) Cadmium induces conformational modifications of wild-type p53 and supresses p53 response to DNA damage in cultured cells, J. Biol. Chem. 274, 31663-31670.
37. Sensi, S. L., Canzoniero, L. M., Yu, S. P., Ying, H. S., Koh, J. Y., Kerchner, G. A., and Choi, D. W. (1997) Measurement of intracellular free zinc in living cortical neurons: routes of entry, J. Neurosci. 17, 9554-9564.
38. Simons, T. J. B. (1991) Intracellular free zinc and zinc buffering in human red blood cells, J. Membr. Biol. 123, 63-71.
39. Meplan, C., Richard, M.-J., and Hainaut, P. (2000) Metallogregulation of the tumor supressor protein p53: zinc mediates the renaturation of p53 after exposure to metal chelators in vitro and in intact cells, Oncogene 19, 5227-5236.
40. Ho, E., and Ames, B. N. (2002) Low intracellular zinc induces oxidative DNA damage, disrupts p53, NFkB, and AP1 DNA binding, and affects DNA repair in a rat glioma cell line, Proc. Natl. Acad. Sci. U.S.A. 99, 16770-16775.